Cooper Cos., which is moving to Pleasanton from Lake Forest, said Wednesday that it settled a patent infringement lawsuit with rival Ciba Vision, the eye care unit of Switzerland’s Novartis AG.
The settlement stems from Cooper and Novartis trading patent infringement suits in April 2006.
CooperVision, Cooper’s dominant contact lens unit, said its suit against Ciba involved a pair of patents, one relating to features controlling contact lenses’ edge characteristics and another relating to design.
Ciba alleged CooperVision infringed on patents relating to silicone hydrogel contact lenses.
Under the settlement, CooperVision will pay a royalty to Novartis on domestic sales of its Biofinity contact lenses until 2014 and on international sales until 2016.
Ciba is licensing patents to CooperVision as part of the deal.
Cooper and Novartis both said additional details of the settlement are confidential.
